Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

8.14.12 is the date Kevetrin ph1 was first listed on clinicaltrials.gov
https://clinicaltrials.gov/beta/show/NCT01664000?term=cellceutix&rank=7

Actual start was October 2012 and the primary completion date was January 2016. The trial was a long one. It lasted 3 years and 2 months.
https://clinicaltrials.gov/beta/show/record/NCT01664000?term=cellceutix&rank=7

CLICK ON PIC TO ENLARGE


First 10-K by Cellceutix was filed 10.8.09 and it shows how they got started. At that time Evans was still CEO.
https://www.sec.gov/Archives/edgar/data/1355250/000135525009000018/form10k.htm

On December 7, 2007, the Company entered into employment agreements with its two executive officers, Mr. George Evans, Chief Executive Officer, and Dr. Krishna Menon, Chief Scientific Officer.

Leo Ehrlich first started loaning the company money in year ending June 2010 per this filing.
https://www.sec.gov/Archives/edgar/data/1355250/000135525010000025/form10k.htm

Leo Ehrlich was listed aa CEO in 10-K filed on 10.13.11 https://www.sec.gov/Archives/edgar/data/1355250/000114420411057659/v237150_10k.htm

Setting up company and getting everything ready for that first p53 trial took time. But, Leo seems to be the one to actually get the ball rolling.

I don't believe you have ten years of evidence. But, perhaps, I'm wrong to view the working timeline of trials from the date of first trial being listed in 2012.






In Reply to 'sixmilliondollarbios'
That's what happens when you spend a decade hyping a drug and only advancing it through P2, when you fail to follow through on your word ( up listing, Prurisol, Brilacidin ABSSSI etc. ), when you put out multiple fluff PRs on a monthly basis and keep issuing shares. The pops get sold. Let's hope Brilacidin OM hits it out of the park. But I wouldn't stay too long after topline. Leo can't seem to partner his pipeline or take anything into pivotal studies. Ten years of evidence is on my side of the argument.